Skip to Content

Brain Bubble

A new drug-delivery device may offer new hope to patients afflicted with glioma-a type of brain tumor that is now invariably fatal. University of Kentucky neuroscientist Roy Patchell has invented a device, called Serodur, that directly administers therapeutic drugs to the tumor. Serodur consists of a silicon bubble implanted under the scalp and a tube that carries drugs from this chamber to the tumor through a flow-regulating membrane. Serodur can be refilled by injecting more medicine through the scalp into the reservoir. Such direct injection allows for a higher dosage and fewer side effects than conventional intravenous chemotherapy, says Patchell. And with its direct line into the brain, Serodur can dispense drugs that are unable to cross the so-called “blood-brain barrier “-including drugs that selectively kill dividing cancerous cells in order to destroy the tumor more effectively. Patchell expects a large-scale national trial of the device to begin next year.

Keep Reading

Most Popular

Geoffrey Hinton tells us why he’s now scared of the tech he helped build

“I have suddenly switched my views on whether these things are going to be more intelligent than us.”

Meet the people who use Notion to plan their whole lives

The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.

Learning to code isn’t enough

Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.

Deep learning pioneer Geoffrey Hinton has quit Google

Hinton will be speaking at EmTech Digital on Wednesday.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.